Bristol-Myers Squibb Co. (BMY): Price and Financial Metrics
BMY Price/Volume Stats
| Current price | $49.13 | 52-week high | $60.55 |
| Prev. close | $48.24 | 52-week low | $39.35 |
| Day low | $48.20 | Volume | 9,412,900 |
| Day high | $49.15 | Avg. volume | 15,111,249 |
| 50-day MA | $46.58 | Dividend yield | 4.98% |
| 200-day MA | $47.72 | Market Cap | 99.59B |
BMY Stock Price Chart Interactive Chart >
Bristol-Myers Squibb Co. (BMY) Company Bio
Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City. BMS is one of the world's largest pharmaceutical companies, and is consistently ranked on the Fortune 500 list of the largest U.S. corporations. As of September 2020, it had the total revenue of $39.3 billion. (Source:Wikipedia)
Latest BMY News From Around the Web
Below are the latest news stories about BRISTOL MYERS SQUIBB CO that investors may wish to consider to help them evaluate BMY as an investment opportunity.
Cytokinetics (CYTK) Up 83% as Cardiomyopathy Drug Meets GoalsCytokinetics (CYTK) reports positive results from its pivotal late-stage study of aficamten in symptomatic obstructive hypertrophic cardiomyopathy patients. The stock rallies 83% in response. |
Biotech Stock Roundup: BMY's KRTX and RYZB Acquisition, CYTK Surges on Study DataBristol Myers (BMY) and Cytokinetics (CYTK) are in the news on acquisition announcements and study updates, respectively. |
Top 15 Value Stocks to Buy for 2024In this article, we discuss top 15 value stocks to buy for 2024 picked by Joel Greenblatt. To skip the details about Mr. Greenblatt’s life, portfolio performance, and investment strategy, go directly to Top 5 Value Stocks to Buy for 2024. Investing offers an exciting and effective way of growing wealth over time. Value investing is […] |
11 Hot Healthcare Stocks To Buy NowIn this article, we will be taking a look at 11 hot healthcare stocks to buy now. To skip our detailed analysis of the healthcare sector, you can go directly to see the 5 Hot Healthcare Stocks To Buy Now. Healthcare is a vital part of daily living for everyone, whether it be to cure […] |
Why Is Cytokinetics (CYTK) Stock Up 70% Today?With Cytokinetics hitting a homerun with its heart failure drug, CYTK stock skyrocketed in part due to takeover interest. |
BMY Price Returns
| 1-mo | -0.47% |
| 3-mo | 22.22% |
| 6-mo | -2.74% |
| 1-year | -12.65% |
| 3-year | -10.38% |
| 5-year | 17.23% |
| YTD | -0.52% |
| 2023 | -26.14% |
| 2022 | 18.98% |
| 2021 | 2.88% |
| 2020 | 0.41% |
| 2019 | 27.74% |
BMY Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Continue Researching BMY
Here are a few links from around the web to help you further your research on Bristol Myers Squibb Co's stock as an investment opportunity:Bristol Myers Squibb Co (BMY) Stock Price | Nasdaq
Bristol Myers Squibb Co (BMY) Stock Quote, History and News - Yahoo Finance
Bristol Myers Squibb Co (BMY) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...